当前位置:首页 - 行情中心 - 索宝蛋白(603231) - 财务分析 - 现金流量表

索宝蛋白

(603231)

  

流通市值:18.34亿  总市值:33.05亿
流通股本:1.06亿   总股本:1.91亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金947,316,933.38482,493,799.221,906,630,887.781,269,190,681.3
  收到的税费返还30,744,687.1115,089,674.2559,397,996.951,398,315.39
  收到其他与经营活动有关的现金95,117,698.3327,236,940.2762,996,329.1344,590,078.92
  经营活动现金流入小计1,073,179,318.82524,820,413.742,029,025,213.811,365,179,075.61
  购买商品、接受劳务支付的现金900,326,929.38417,274,979.21,433,660,400.791,035,263,652.11
  支付给职工以及为职工支付的现金76,204,698.3442,130,248.9124,445,460.1789,272,952.15
  支付的各项税费24,769,681.513,024,380.5853,725,012.7241,434,208.22
  支付其他与经营活动有关的现金63,991,460.6440,773,814.21106,088,364.970,183,473.06
  经营活动现金流出小计1,065,292,769.86513,203,422.891,717,919,238.581,236,154,285.54
  经营活动产生的现金流量净额7,886,548.9611,616,990.85311,105,975.23129,024,790.07
二、投资活动产生的现金流量:
  取得投资收益收到的现金3,854,286.28407,720.9212,413,098.057,615,455.43
  处置固定资产、无形资产和其他长期资产收回的现金净额94,936.588,748.5213,778.89187,210
  收到的其他与投资活动有关的现金645,600,000140,400,0002,767,080,0001,902,780,000
  投资活动现金流入小计649,549,222.78140,896,469.422,779,706,876.941,910,582,665.43
  购建固定资产、无形资产和其他长期资产支付的现金36,084,038.6520,529,660.79189,990,622.9689,868,075.29
  支付其他与投资活动有关的现金548,867,50085,000,0002,923,509,444.442,058,809,444.44
  投资活动现金流出小计584,951,538.65105,529,660.793,113,500,067.42,148,677,519.73
  投资活动产生的现金流量净额64,597,684.1335,366,808.63-333,793,190.46-238,094,854.3
三、筹资活动产生的现金流量:
  吸收投资收到的现金2,100,0002,000,000--
  其中:子公司吸收少数股东投资收到的现金2,100,0002,000,000--
  取得借款收到的现金83,774,00043,774,00047,548,00047,548,000
  筹资活动现金流入小计85,874,00045,774,00047,548,00047,548,000
  偿还债务支付的现金43,774,00043,774,00047,548,00047,548,000
  分配股利、利润或偿付利息支付的现金71,050,013.1413,480,226.3457,493,061.5357,494,904.01
  支付其他与筹资活动有关的现金775,406.03535,406.031,532,821.031,292,821.03
  筹资活动现金流出小计115,599,419.1757,789,632.37106,573,882.56106,335,725.04
  筹资活动产生的现金流量净额-29,725,419.17-12,015,632.37-59,025,882.56-58,787,725.04
四、汇率变动对现金及现金等价物的影响-8,346,883.12-4,214,952.37333,651.317,013,825.83
五、现金及现金等价物净增加额34,411,930.830,753,214.74-81,379,446.48-160,843,963.44
  加:期初现金及现金等价物余额238,641,900.93238,641,900.93320,021,347.41320,021,347.41
  期末现金及现金等价物余额273,053,831.73269,395,115.67238,641,900.93159,177,383.97
补充资料:
  净利润67,111,886.82-189,716,351.28-
  资产减值准备--2,347,992.39-
  固定资产和投资性房地产折旧40,922,509.47-74,641,553.79-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧40,922,509.47-74,641,553.79-
  无形资产摊销1,228,548.63-2,462,239.81-
  处置固定资产、无形资产和其他长期资产的损失-7,812.6--30,270.73-
  固定资产报废损失221,798.12-3,609,819.03-
  公允价值变动损失-2,877,809.29--5,275,163.24-
  财务费用288,301.76-80,950.04-
  投资损失-955,983.47--2,838,359.07-
  递延所得税-409,568.95--212,967.31-
  其中:递延所得税资产减少-764,972.62-777,637.15-
    递延所得税负债增加355,403.67--990,604.46-
  存货的减少-86,852,004.51-35,564,417.58-
  经营性应收项目的减少-67,998,999.58--28,268,121.51-
  经营性应付项目的增加47,519,329.58-37,495,123.03-
  其他8,346,883.12--310,592.1-
  现金的期末余额273,053,831.73-238,641,900.93-
  减:现金的期初余额238,641,900.93-320,021,347.41-
  现金及现金等价物的净增加额34,411,930.8--81,379,446.48-
公告日期2026-08-282026-04-302026-04-242025-10-31
审计意见(境内)标准无保留意见
TOP↑